Patent Document ID: 20080166719
Application ID: 11841660
Patent Flag: 0

Claim One:
1. A method for classifying whether a sample from an individual is associated with irritable bowel syndrome (IBS), said method comprising: (a) determining a diagnostic marker profile by detecting the presence or level of at least one diagnostic marker selected from the group consisting of a cytokine, growth factor, anti-neutrophil antibody, anti- Saccharomyces cerevisiae antibody (ASCA), antimicrobial antibody, lactoferrin, anti-tissue transglutaminase (tTG) antibody, lipocalin, matrix metalloproteinase (MMP), tissue inhibitor of metalloproteinase (TIMP), alpha-globulin, actin-severing protein, S100 protein, fibrinopeptide, calcitonin gene-related peptide (CGRP), tachykinin, ghrelin, neurotensin, corticotropin-releasing hormone, and combinations thereof in said sample; and (b) classifying said sample as an IBS sample or non-IBS sample using an algorithm based upon said diagnostic marker profile.